Breaking News
Sort by:
Top Post
ProPharma Acquires UK Based Digital Lab Consulting
ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]
Viome Life Sciences Unveils CancerDetect™, the Future of Oral and Throat Cancer Detection
Viome Life Sciences, a mission-driven biotechnology company, announces the arrival of its CancerDetect™ test for oral […]
New Two-year Data Confirm Roche’s Vabysmo Improves Vision With Fewer Treatments for People With Neovascular Age-related Macular Degeneration
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new two-year data from the TENAYA and […]
Remington Announces Launch of VascuChek®, A Wireless, Vascular Doppler Device
Remington Medical, a medical device manufacturing company based in the U.S., announced the launch of […]
Telix and RefleXion Expand Partnership for Prostate Cancer Treatment
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and RefleXion Medical, Inc. (Hayward, California, U.S.) (RefleXion) […]
Theolytics Starts a £1m Project in Collaboration With the University of Sheffield, Supported by Innovate UK to Develop a Novel Therapy for Multiple Myeloma Patients
Theolytics is a biotechnology company harnessing viruses to combat disease. The company has been awarded […]
Optibrium Strengthens Global AI Drug Discovery Software Operations With Three Key Appointments
Optibrium, a leading developer of software and artificial intelligence (AI) solutions for drug discovery, today […]
Pfizer Completes Acquisition of Biohaven Pharmaceuticals
Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Biohaven Pharmaceutical Holding […]
Liverpool Heart and Chest Hospital Selects Clinical Informatics Provider Epro as Digital Partner
Leading healthcare informatics provider Epro has been selected by the Liverpool Heart and Chest Hospital (LHCH) to […]
Chinese NMPA Approves Study of Telix Kidney Cancer Imaging Candidate
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Chinese National Medical Products […]
- MedRhythms Feasibility Study Shows Positive Topline Results in Parkinson’s Disease Read more
- Ionis receives FDA Fast Track designation for Olezarsen in patients with Familial Chylomicronemia Syndrome Read more
- Sensorion and EVEON Collaborating to Develop an Injection System for the Delivery of Gene Therapy Treatments Into the Inner Ear Read more
- Qurient Announces Dosing of First Patient in Clinical Study for the Treatment of Patients with Solid Tumors Read more
- Marinus Pharmaceuticals Appoints Christine Silverstein to its Board of Directors Read more